MA39126A2 - Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci - Google Patents
Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ciInfo
- Publication number
- MA39126A2 MA39126A2 MA39126A MA39126A MA39126A2 MA 39126 A2 MA39126 A2 MA 39126A2 MA 39126 A MA39126 A MA 39126A MA 39126 A MA39126 A MA 39126A MA 39126 A2 MA39126 A2 MA 39126A2
- Authority
- MA
- Morocco
- Prior art keywords
- progesterone
- intermediates
- enantiomeric synthesis
- enantiomeric
- synthesis
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 4
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 229960003387 progesterone Drugs 0.000 title abstract 2
- 239000000186 progesterone Substances 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
- C07J15/005—Retrosteroids (9 beta 10 alfa)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
La présente invention concerne la synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919420P | 2013-12-20 | 2013-12-20 | |
| PCT/US2014/070879 WO2015095339A1 (fr) | 2013-12-20 | 2014-12-17 | Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MA39126A2 true MA39126A2 (fr) | 2018-08-31 |
| MA39126A3 MA39126A3 (fr) | 2019-04-30 |
| MA39126B1 MA39126B1 (fr) | 2020-03-31 |
Family
ID=53399300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39126A MA39126B1 (fr) | 2013-12-20 | 2014-12-17 | Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20150175650A1 (fr) |
| EP (1) | EP3083656A1 (fr) |
| JP (1) | JP2017502031A (fr) |
| CN (1) | CN105980396B (fr) |
| AR (1) | AR098879A1 (fr) |
| AU (1) | AU2014364850A1 (fr) |
| BR (1) | BR112016014000A2 (fr) |
| CA (1) | CA2934466A1 (fr) |
| EA (1) | EA201691074A1 (fr) |
| IL (1) | IL246258A0 (fr) |
| MA (1) | MA39126B1 (fr) |
| MX (1) | MX2016008167A (fr) |
| PH (1) | PH12016501201A1 (fr) |
| SG (1) | SG11201604982XA (fr) |
| TN (1) | TN2016000252A1 (fr) |
| TW (1) | TW201538519A (fr) |
| UY (1) | UY35909A (fr) |
| WO (1) | WO2015095339A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017100988A (ja) * | 2015-12-01 | 2017-06-08 | アサヒグループホールディングス株式会社 | 光学活性なヒドロキシ脂肪酸の製造方法 |
| IT201700004904A1 (it) * | 2017-01-18 | 2018-07-18 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE) |
| MX2022001449A (es) * | 2019-08-02 | 2022-04-06 | Enterin Inc | Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos. |
| CA3149480A1 (fr) * | 2019-08-02 | 2021-02-11 | Enterin, Inc. | Derives de squalamine humaine, compositions associees les comprenant, et procedes d'utilisation correspondants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2955684A1 (fr) * | 2008-02-26 | 2009-09-03 | Emory University | Analogues steroidiens utilises en neuroprotection |
| WO2010088409A2 (fr) * | 2009-01-30 | 2010-08-05 | Emory University | Procédés de neuroprotection utilisant des stéroïdes neuroprotecteurs et une vitamine d |
| WO2013052849A2 (fr) * | 2011-10-07 | 2013-04-11 | Florida State University Research Foundation | Utilisation prophylactique et en phase post-aiguë de progestérone pour améliorer des résultats associés à une commotion |
-
2014
- 2014-12-17 CN CN201480072282.4A patent/CN105980396B/zh not_active Expired - Fee Related
- 2014-12-17 US US14/573,656 patent/US20150175650A1/en not_active Abandoned
- 2014-12-17 TN TN2016000252A patent/TN2016000252A1/en unknown
- 2014-12-17 SG SG11201604982XA patent/SG11201604982XA/en unknown
- 2014-12-17 CA CA2934466A patent/CA2934466A1/fr not_active Abandoned
- 2014-12-17 AU AU2014364850A patent/AU2014364850A1/en not_active Abandoned
- 2014-12-17 MA MA39126A patent/MA39126B1/fr unknown
- 2014-12-17 JP JP2016541444A patent/JP2017502031A/ja active Pending
- 2014-12-17 EP EP14871117.9A patent/EP3083656A1/fr not_active Withdrawn
- 2014-12-17 BR BR112016014000A patent/BR112016014000A2/pt not_active IP Right Cessation
- 2014-12-17 EA EA201691074A patent/EA201691074A1/ru unknown
- 2014-12-17 MX MX2016008167A patent/MX2016008167A/es unknown
- 2014-12-17 WO PCT/US2014/070879 patent/WO2015095339A1/fr not_active Ceased
- 2014-12-19 TW TW103144457A patent/TW201538519A/zh unknown
- 2014-12-19 UY UY0001035909A patent/UY35909A/es not_active Application Discontinuation
- 2014-12-19 AR ARP140104814A patent/AR098879A1/es unknown
-
2016
- 2016-06-16 IL IL246258A patent/IL246258A0/en unknown
- 2016-06-20 PH PH12016501201A patent/PH12016501201A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201538519A (zh) | 2015-10-16 |
| JP2017502031A (ja) | 2017-01-19 |
| BR112016014000A2 (pt) | 2017-08-08 |
| CN105980396B (zh) | 2019-03-22 |
| WO2015095339A1 (fr) | 2015-06-25 |
| US20150175650A1 (en) | 2015-06-25 |
| IL246258A0 (en) | 2016-08-02 |
| PH12016501201A1 (en) | 2016-08-15 |
| UY35909A (es) | 2015-07-31 |
| EP3083656A1 (fr) | 2016-10-26 |
| MA39126A3 (fr) | 2019-04-30 |
| EA201691074A1 (ru) | 2017-02-28 |
| AR098879A1 (es) | 2016-06-22 |
| SG11201604982XA (en) | 2016-07-28 |
| MA39126B1 (fr) | 2020-03-31 |
| TN2016000252A1 (en) | 2017-10-06 |
| CA2934466A1 (fr) | 2015-06-25 |
| CN105980396A (zh) | 2016-09-28 |
| MX2016008167A (es) | 2017-04-27 |
| AU2014364850A1 (en) | 2016-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39095A1 (fr) | Anticorps et immunoconjugués anti-cd33 | |
| MA40682A (fr) | Anticorps anti-ox40 et procédés d'utilisation correspondants | |
| MA43018B1 (fr) | Anticorps anti-pd1 et procédés d'utilisation | |
| MA40576B1 (fr) | Anticorps et immunoconjugués anti-her2 | |
| TWD179056S (zh) | 充電器 | |
| MA38632B1 (fr) | Anticorps anti-récepteur de transferrine et procédés d'utilisation | |
| TWD180147S (zh) | 淨水器 | |
| UY34721A (es) | Anticuerpos anti-hla-b*27 y usos de éstos. | |
| JOP20140114B1 (ar) | مركبات حلقية غير متجانسة واستخداماتها | |
| TWD176865S (zh) | 滴定儀器 | |
| TWD174041S (zh) | 手錶 | |
| IN2013MU00848A (fr) | ||
| TWD174040S (zh) | 錶 | |
| PH12016500683B1 (en) | Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines | |
| TWD187227S (zh) | 淨水器 | |
| TWD173011S (zh) | 手錶 | |
| EA201690263A1 (ru) | Улучшенные способы получения перампанеля | |
| MA39126A3 (fr) | Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci | |
| EP2989568A4 (fr) | Détermination de l'importance d'attributs | |
| EP2726636A4 (fr) | Elucidation de l'identite de metabolites inconnus | |
| MA39411A (fr) | Synthèse de l'énantiomère de la progestérone et ses intermédiaires | |
| TWD166471S (zh) | 手錶 | |
| MX2015012902A (es) | Sintesis de ent-progesterona e intermediarios de la misma. | |
| EP2946006A4 (fr) | Biocatalyseurs modifiés utiles pour la synthèse de carbapénème | |
| MX384260B (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. |